- New Drugs on the Horizon Sessions Unveiled 12 Therapeutics at AACR Annual Meeting 2025
- Editors’ Picks, May 2025: High-Altitude Oxygen Adaptations, Fossil Fuel Exposure Risks, and More
- AACR Annual Meeting 2025 Plenaries: Cancer Evolution, Tumor Microenvironment, Drugging KRAS, and More
- Navigating the Meandering Path of Oncology Drug Development
- From the Bench, Spring 2025: Making Tumors Pig-like, Transplanting Fat Cells, and Other Creative Approaches in Cancer Research
- The Impact of Funding Cuts: AACR Annual Meeting 2025 Shows Why Cancer Research Matters
- What Is a Gleason Score for Prostate Cancer?
- Breakthroughs in the Blood: Leveraging Liquid Biopsy to Improve Cancer Care
- Old, New, Borrowed, and Blue: Clinical Trial Results Highlight Therapeutic Approaches for Non-small Cell Lung Cancer
- Presidential Symposium Showcases Global Researchers Tackling Cancer Burden
- Editors’ Picks, April 2025: Brain Cancer Evolution, New Treatment Approaches, and More
- Daily Takeaways From the AACR Annual Meeting 2025: Wednesday, April 30
- Pembrolizumab’s Perioperative Power in Head and Neck Cancer
- Daily Takeaways From the AACR Annual Meeting 2025: Tuesday, April 29
- Daily Takeaways From the AACR Annual Meeting 2025: Monday, April 28